C-Path, IMI to benchmark PPP performance

The Critical Path Institute (C-Path) and EU's Innovative Medicines Initiative (IMI) will host their second joint conference on Dec. 3 to discuss the benchmarks for public-private partnerships in biopharmaceutical development. ...